Posts

Posted on

Xylo Technologies: Revoltz Launches Commercial Phase of PORTO EV in Israel with First 50 Vehicles Delivered to Exclusive Distributor

Marks First Global Commercial Rollout of the Innovative Last-Mile Micro EV

TEL AVIV, Israel, April 10, 2025 (GLOBE NEWSWIRE) — Xylo Technologies Ltd. (Nasdaq: XYLO) (“Xylo” or the “Company”), a technology-based company engaged in advanced innovative technologies, announced today that Revoltz Ltd. (“Revoltz”), which is 19.9% held by Charging Robotics, Inc. (OTC: CHEV) (“Charging Robotics”), a Delaware corporation quoted on the OTC Market (62.22% owned by Xylo), has started the official launch of its commercial phase in Israel for the PORTO EV, its flagship electric micro vehicle tailored for last-mile delivery. This milestone follows the recent regulatory approval by the Israeli Standards Institute and signifies the first global commercial deployment of the PORTO EV.

Built for agility and function, the PORTO EV features:

  • High-volume cargo space over both axles
  • Full-day range on a single charge
  • License-free operation for users 16+ (under Israeli regulation)

Revoltz has delivered the first 50 units to its exclusive distributor in Israel, initiating sales operations across key urban centers. This delivery is part of a previously announced five-year, $2.7 million distribution agreement, which includes an initial commitment of 150 vehicles in the first year. The five-year agreement includes annual milestones and scaled-up sales targets, with the distributor providing service and maintenance for the PORTO EVs, focusing mainly on the local delivery market.

“This marks a major leap from development to deployment,” said Amir Zaid, CEO and co-founder of Revoltz. “Starting commercial sales in Israel validates the strong demand for sustainable, high-performance solutions in last-mile delivery. We are excited to see PORTO EVs hit the streets and contribute to cleaner, more efficient urban transport.”

The Israeli distributor will manage sales, service, and maintenance operations and is actively targeting local delivery fleets, logistics companies, and small businesses seeking cost-effective and environmentally friendly urban mobility.

The commercial rollout comes as the demand for compact electric vehicles continues to rise, particularly in dense urban environments where noise, pollution, and congestion are key concerns.

About Xylo

Based in Israel, Xylo Technologies Ltd. (Nasdaq: XYLO) is a technology company focused on innovative growth partnerships, mainly in the advanced medical solutions, digital commerce, and electric vehicle markets. Xylo’s affiliations in the medical solutions arena include ownership in Polyrizon Ltd. The Company’s affiliates in digital commerce include Gix Internet Ltd. and Eventer Technologies Ltd. In the electric vehicle market, Charging Robotics, Inc. and Revoltz Ltd. are also part of the Company’s portfolio of technology solution providers. Other affiliations of the Company include Zig Miami 54 LLC.

Xylo is traded on The Nasdaq Capital Market. To learn more about Xylo’s advanced technologies, please visit  https://ir.xylotech.ai/.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,” and similar expressions or variations of such words are intended to identify forward-looking statements. Because such statements deal with future events and are based on Xylo’s current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements of Xylo could differ materially from those described in or implied by the statements in this press release. For example, Xylo cannot guarantee the impact of the PORTO EV’s commercial launch in Israel on Revoltz’s financial or operational results.

The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed in any filings with the SEC. Except as otherwise required by law, Xylo undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Xylo is not responsible for the contents on third-party websites.

Company Contact:

Tali Dinar
Chief Financial Officer
[email protected]

Investor Relations Contact:

Michal Efraty
Investor Relations,
[email protected]



Posted on

Instacart to Report First Quarter 2025 Financial Results on May 1, 2025

PR Newswire


SAN FRANCISCO
, April 10, 2025 /PRNewswire/ — Instacart (NASDAQ: CART) today announced it will report its first quarter 2025 financial results after market close on Thursday, May 1, 2025. The company’s first quarter 2025 Shareholder Letter will be available on Instacart’s Investor Relations website at https://investors.instacart.com.

Instacart management will also host a conference call to discuss the company’s results at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on Thursday, May 1. To access a live webcast of the conference call, please visit the Investor Relations website at https://investors.instacart.com. After the call concludes, a replay will be made available on the Investor Relations website.

Instacart uses and intends to continue to use its Investor Relations website as a means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation FD. Accordingly, investors should monitor Instacart’s Investor Relations website, press releases, SEC filings, public conference calls, and public webcasts, in addition to following Instacart’s blog, which is located at www.instacart.com/company/blog.

About Instacart

Instacart, the leading grocery technology company in North America, works with grocers and retailers to transform how people shop. The company partners with more than 1,800 national, regional, and local retail banners to facilitate online shopping, delivery and pickup services from nearly 100,000 stores across North America on the Instacart Marketplace. Instacart makes it possible for millions of people to get the groceries they need from the retailers they love, and for approximately 600,000 Instacart shoppers to earn by picking, packing and delivering orders on their own flexible schedule. The Instacart Platform offers retailers a suite of enterprise-grade technology products and services to power their e-commerce experiences, fulfill orders, digitize brick-and-mortar stores, provide advertising services, and glean insights. With Instacart Ads, thousands of CPG brands – from category leaders to emerging brands – partner with the company to connect directly with consumers online, right at the point of purchase. With Instacart Health, the company is providing tools to increase nutrition security, make healthy choices easier for consumers, and expand the role that food can play in improving health outcomes. For more information, visit www.instacart.com/company, and to start shopping, visit www.instacart.com. Maplebear Inc. is the registered corporate name of Instacart.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/instacart-to-report-first-quarter-2025-financial-results-on-may-1-2025-302425383.html

SOURCE Instacart

Posted on

The Scotts Miracle-Gro Foundation and KidsGardening Announce the 2025 GroMoreGood Grassroots Grantees

MARYSVILLE, Ohio, April 10, 2025 (GLOBE NEWSWIRE) — To connect more children to gardens and outdoor play, The Scotts Miracle-Gro Foundation and KidsGardening are awarding grants to 170 community-level programs under the annual GroMoreGood Grassroots Grant initiative.

From spring through fall, the programs will start or expand youth gardens and green spaces. Selections for the 2025 GroMoreGood grant recipients were based upon the learning impact, including factors such as individual program participants, prior funding and socioeconomic reach, among others.

“We are grateful to partner with The Scotts Miracle-Gro Foundation to support the GroMoreGood Grassroots Grants and bring the transformative power of gardens to communities nationwide,” says Em Shipman, KidsGardening executive director. “This year’s recipients are truly inspiring—restoring gardens after natural disasters, creating inclusive spaces for youth with disabilities and revitalizing community gardens for after-school programs.”

The 2025 recipients span 44 states across the country and anticipate connecting more than 38,000 youth with garden-based learning opportunities. For a full list of GroMoreGood Grassroots grantees, visit GroMoreGood Grassroots Grant Winners.

“This year was notable with the number of unique proposals that reflected the challenges and opportunities many communities are facing,” said Brian Herrington, president of The Scotts Miracle-Gro Foundation. “We’re confident these grantees not only will help foster a growing appreciation for gardens and green spaces, but also create positive experiences grounded in their many environmental, health and wellness benefits.”

Awards were distributed to the winners at the end of March 2025.

About The Scotts Miracle-Gro Foundation

The mission of The Scotts Miracle-Gro Foundation is to inspire, connect and cultivate a community of purpose. The Foundation is deeply rooted in helping create healthier communities, empower the next generation, and preserve our planet. The Foundation is a 501(c)(3) organization that funds non-profit entities that support its core initiatives in the form of grants, endowments and multi-year capital gifts. For more information, visit www.scottsmiraclegrofoundation.org.

About KidsGardening

KidsGardening is a national nonprofit organization creating opportunities for kids to play, learn, and grow through gardening. They provide grants and original educational materials to more than 2.7 million kids across the country. For more information and to support their work, visit www.kidsgardening.org.

For media inquiries: Katherine Dickens Director, ESG and Social Impact
[email protected]

Beth Saunders KidsGardening Marketing and Communications Director
[email protected]



Posted on

Tyler Technologies Schedules First Quarter 2025 Earnings Conference Call and Webcast

Tyler Technologies Schedules First Quarter 2025 Earnings Conference Call and Webcast

PLANO, Texas–(BUSINESS WIRE)–Tyler Technologies, Inc. (NYSE: TYL) will discuss its first quarter 2025 results during a conference call and webcast on Thursday, April 24, 2025. The teleconference begins at 10:00 a.m. ET and will be hosted by H. Lynn Moore Jr., president and CEO; and Brian K. Miller, executive vice president and CFO. The related press release will be issued after the market closes on Wednesday, April 23.

Participants can pre-register for the teleconference at the following link:https://registrations.events/direct/Q4I56323447.Registered participants will receive an email with a calendar reminder, dial-in number, and access code that allows immediate access to the call on Thursday, April 24, 2025. Alternatively, participants can also join the teleconference by dialing 646-307-1963. Participants must advise the operator of the conference name before admittance.

The live audio webcast and archived replay can also be accessed at the Events & Presentations section of Tyler’s investor relations website.

About Tyler Technologies, Inc.

Tyler Technologies (NYSE: TYL) is a leading provider of integrated software and technology services for the public sector. Tyler’s end-to-end solutions empower local, state, and federal government entities to operate efficiently and transparently with residents and each other. By connecting data and processes across disparate systems, Tyler’s solutions transform how clients turn actionable insights into opportunities and solutions for their communities. Tyler has more than 45,000 successful installations across 13,000 locations, with clients in all 50 states, Canada, the Caribbean, Australia, and other international locations. Tyler has been recognized numerous times for growth and innovation, including on Government Technology’s GovTech 100 list. More information about Tyler Technologies, an S&P 500 company headquartered in Plano, Texas, can be found at tylertech.com.

#TYL_Financial

Hala Elsherbini

Senior Director, Investor Relations

Tyler Technologies, Inc.

972-713-3722

[email protected]

KEYWORDS: United States North America Texas

INDUSTRY KEYWORDS: Data Management Public Policy/Government State/Local Technology Other Technology Software

MEDIA:

Logo
Logo
Posted on

Life Time to Report First Quarter 2025 Financial Results on May 8, 2025

PR Newswire


CHANHASSEN, Minn.
, April 10, 2025 /PRNewswire/ — Life Time Group Holdings, Inc. (“Life Time” or the “Company”) (NYSE: LTH) today announced that its financial results for first quarter 2025 will be released before market open on Thursday, May 8, 2025. The Company will host a conference call at 10:00 a.m. ET that day to discuss the financial results and provide a business update.

How to Participate:

  • Date: Thursday, May 8, 2025
  • Time: 10:00 a.m. ET (9:00 a.m. CT)
  • U.S. dial-in number: 1-877-451-6152
  • International dial-in number: 1-201-389-0879
  • Webcast:

    LTH 1Q 2025 Earnings Call

A link to the live audio webcast of the conference call will also be available at https://ir.lifetime.life.

Replay Information:

  • Webcast – A recorded replay of the webcast will be available within approximately three hours of the conclusion of the call and may be accessed online at https://ir.lifetime.life.
  • Conference Call – The replay of the conference call will be available after 1:00 p.m. ET the same day through May 22, 2025:

    • U.S. replay number: 1-844-512-2921
    • International replay number: 1-412-317-6671
    • Replay ID: 1375 3137


About Life Time

Life Time (NYSE: LTH) empowers people to live healthy, happy lives through its portfolio of 180 athletic country clubs across the United States and Canada, the complimentary, comprehensive Life Time app and nearly 30 of the most iconic athletic events in the country. The health and wellness pioneer uniquely serves people 90 days to 90+ years old through its healthy living, healthy aging, healthy entertainment communities and ecosystem, along with a range of healthy way of life programs and information, and the most trusted LTH nutritional supplements and products. Life Time was recently certified as a Great Place to Work®, reinforcing its commitment to fostering an exceptional workplace culture on behalf of its more than 42,000 dedicated team members.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/life-time-to-report-first-quarter-2025-financial-results-on-may-8-2025-302425669.html

SOURCE Life Time Group Holdings, Inc.

Posted on

Acme United to Release First Quarter 2025 Financial Results on April 17, 2025

SHELTON, Conn., April 10, 2025 (GLOBE NEWSWIRE) — Acme United Corporation (NYSE American: ACU) will release its financial results for the first quarter of 2025 on Thursday, April 17, 2025, at 9:00 AM Eastern Time.

A conference call to discuss these results will be broadcast over the internet on Thursday, April 17, 2025, at 12:00 p.m. Eastern Time. To listen or participate in a question-and-answer session, dial 1- 877-407-0784, international callers dial 1- 201-689-8560, conference ID: 13752605.

Access to the live webcast of the conference call can be found in the Investor Relations section of the Company’s website, www.acmeunited.com. A replay can be accessed under Investor Relations, Audio Archives.

About Acme United

ACME UNITED CORPORATION is a leading worldwide supplier of innovative safety solutions and cutting technology to the school, home, office, hardware, sporting goods and industrial markets. Its leading brands include First Aid Only®, First Aid Central®, PhysiciansCare®, Spill Magic®, Westcott®, Clauss®, DMT®, Med-Nap, Safety Made and Elite. For more information, visit www.acmeunited.com.

Contacts

Acme United Corporation
Paul G. Driscoll, 203-254-6060
[email protected]



Posted on

Silynxcom Receives $1.1 Million Order from Israel Defense Forces

Significant New Order Further Strengthens Silynxcom’s Position as a Trusted Supplier of Advanced Tactical Communication Solutions

Netanya, Israel, April 10, 2025 (GLOBE NEWSWIRE) — Silynxcom Ltd. (NYSE American: SYNX) (“Silynxcom” or the “Company”), a manufacturer and developer of ruggedized tactical communication headset devices, today announced it has received a new purchase order valued at approximately $1.13 million from the Israel Defense Forces (“IDF”).

The Company believes that this significant new order underscores the IDF’s continued confidence in Silynxcom’s advanced tactical communication solutions and further solidifies the Company’s position as a trusted supplier to one of the world’s most technologically advanced military forces.

“We are pleased to announce this substantial new order from the IDF, which highlights the critical role our tactical communication systems play in enhancing operational capabilities for military personnel,” said Nir Klein, Chief Executive Officer of Silynxcom. “Our ongoing relationship with the IDF continues to validate the effectiveness and reliability of our products in the most demanding environments. We believe that this order reinforces our strong position in the global defense market as we continue to deliver innovative communication solutions that meet the evolving needs of modern military forces.”

Silynxcom’s ruggedized tactical communication headset devices provide superior audio clarity, enhanced situational awareness, and exceptional hearing protection while maintaining clear communication in high-noise environments. The Company’s products have been field-tested and combat-proven, designed to perform reliably under the most challenging operational conditions.

This order follows several significant contracts announced by the Company in recent months, further demonstrating the growing demand for Silynxcom’s advanced tactical communication solutions across military and law enforcement organizations worldwide.

About Silynxcom Ltd.

Silynxcom Ltd. develops, manufactures, markets, and sells ruggedized tactical communication headset devices as well as other communication accessories, all of which have been field-tested and combat-proven. The Company’s in-ear headset devices, or In-Ear Headsets, are used in combat, the battlefield, riot control, demonstrations, weapons training courses, and on the factory floor. The In-Ear Headsets seamlessly integrate with third party manufacturers of professional-grade ruggedized radios that are used by soldiers in combat or by police officers in leading military and law enforcements units. The Company’s In-Ear Headsets also fit tightly into the protective gear to enable users to speak and hear clearly and precisely while they are protected from the hazardous sounds of combat, riots or dangerous situations. The sleek, lightweight, In-Ear Headsets include active sound protection to eliminate unsafe sounds, while maintaining ambient environmental awareness, giving their customers 360° situational awareness. The Company works closely with its customers and seek to improve the functionality and quality of the Company’s products based on actual feedback from soldiers and police officers “in the field.” The Company sells its In-Ear Headsets and communication accessories directly to military forces, police and other law enforcement units. The Company also deals with specialized networks of local distributors in each locale in which it operates and has developed key strategic partnerships with radio equipment manufacturers.

For additional informaiton about the company please visit: https://silynxcom.com

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws and are subject to substantial risks and uncertainties. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “target,” “aim,” “should,” “will” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. For example, the Company uses forward-looking statements when it discusses: the belief that the order underscores the IDF’s continued confidence in the Company’s advanced tactical communication solutions and solidifies the Company’s position as a trusted supplier to the IDF, that this order highlights the critical role the Company’s tactical communication systems play in enhancing operational capabilities for military personnel, the belief that the Company’s relationship with the IDF continues to validate the effectiveness and reliability of its products in the most demanding environments, the belief that this order reinforces its strong position in the global defense market, the belief in the effectiveness of the Company’s products, and the belief that recent orders demonstrate growing demand for the Company’s advanced tactical communication solutions across military and law enforcement organizations worldwide. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully in the section titled “Risk Factors” in the Company’s Annual Report on Form 20-F for the year ended December 31, 2023 filed with the U.S. Securities and Exchange Commission (the “SEC”) on April 30, 2024, and other documents filed with or furnished to the SEC which are available on the SEC’s website, www.sec.gov. The Company cautions you not to place undue reliance on any forward-looking statements, which speak only as of the date they are made. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Capital Markets & IR Contact

Michal Efraty
[email protected]



Posted on

Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery

Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery

  • Hemopatch Sealing Hemostat with room temperature storage now available in Europe
  • New product evolution enables direct accessibility in the operating room
  • Innovation is a direct result of collaborative efforts with surgeons, helping to ensure that customer needs are met and promoting enhanced patient care

VIENNA–(BUSINESS WIRE)–
Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the introduction of Hemopatch Sealing Hemostat with room temperature storage at a symposium in Austria. The evolution of the product optimizes accessibility in the operating room, delivering an immediate solution for surgeons to control bleeding or prevent leakage. The product is now available to order throughout Europe.

“For over a decade, Hemopatch Sealing Hemostat has offered surgeons a reliable solution for tissue sealing, dura sealing, and hemostasis,” said Steve Wallace, president, Advanced Surgery at Baxter. “The product evolution to include room temperature storage is a result of close collaboration between surgeons and Baxter. Removing the need for refrigeration addresses the needs of our customers to have the product on hand in critical situations. We are proud to continue Baxter’s legacy of innovation in sealing and hemostasis.”

Hemopatch Sealing Hemostat is a ready-to-use absorbable collagen pad intended for tissue sealing, dura sealing and hemostasis, and is effective and safe to use in open surgery and minimally invasive surgery. In a registry of real-world data across Europe, the product has been shown to achieve rapid and sustainable hemostasis in many surgical specialties.1

General Surgeon, Prof. Dr. med. Selman Uranüs said, “More than 10 years ago, I first used Hemopatch Sealing Hemostat for experimental testing. Since then, I have been using it in my daily practice because of its unique characteristics as a sealing hemostatic patch, especially in laparoscopic surgery. In my opinion, eliminating the need for refrigeration and increasing product shelf life are crucial improvements because it enables surgeons to have the product available in the operating room when it matters most. After application, the product shows an enhanced adhesive strength supporting us surgeons to achieve better surgical outcomes.”2

For more information on Hemopatch Sealing Hemostat with room temperature storage, visit https://advancedsurgery.baxter.eu/hemopatch

About Hemopatch Sealing Hemostat

Hemopatch Sealing Hemostat consists of a soft, thin, pliable, flexible pad of collagen derived from bovine dermis, coated with NHS-PEG (pentaerythritol polyethylene glycol ether tetra-succinimidyl glutarate). Due to its flexible structure, the application of Hemopatch Sealing Hemostat to the site where hemostasis / sealing is desired is easily controlled. For differentiation, the non-coated side is marked with blue squares using a biocompatible colorant.3

About Baxter

Every day, millions of patients, caregivers and healthcare providers rely on Baxter’s leading portfolio of diagnostic, critical care, nutrition, hospital and surgical products used across patient homes, hospitals, physician offices and other sites of care. For more than 90 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers who make it happen. With products, digital health solutions and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on X, LinkedIn and Facebook.

INDICATIONS

Hemopatch Sealing Hemostat is indicated as a hemostatic device and surgical sealant across various soft tissues (cardiovascular, connective tissue, parenchyma, serosa, viscera), and dura for procedures in which control of mild or moderate bleeding or leakage of other body fluids or air by conventional surgical techniques is either ineffective or impractical. Hemopatch Sealing Hemostat may be used to augment dura closure techniques to close small dural defects (≤3mm) following traumatic injury, excision, retraction or shrinkage of the dura mater.

IMPORTANT RISK INFORMATION

  • Hemopatch Sealing Hemostat is not recommended to be used in pulsatile, severe bleedings.
  • The use of Hemopatch Sealing Hemostat is not recommended in the presence of an active infection.
  • When used in, around, or in proximity to foramina in bone, areas of bony confine, the spinal cord, the brain and/or cranial nerves, care should be exercised to avoid overpacking as Hemopatch Sealing Hemostat may expand upon absorption of liquid, creating the potential for neural damage.
  • Hemopatch Sealing Hemostat is not intended as a substitute for meticulous surgical technique and the proper application of ligatures or other conventional procedures for hemostasis and sealing.
  • Do not compress Hemopatch Sealing Hemostat into blood vessels or use intravascularly.

Rx Only. For safe and proper use please refer to full device Instructions for Use for Contraindications, Warnings, and Precautions.

Forward-Looking Statements

This release includes forward-looking statements concerning potential benefits associated with Hemopatch Sealing Hemostat. The statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: demand for and market acceptance for new and existing products; product development risks; inability to create additional production capacity in a timely manner or the occurrence of other manufacturing or supply difficulties (including as a result of natural disasters, public health crises and epidemics/pandemics, regulatory actions or otherwise); satisfaction of regulatory and other requirements; actions of regulatory bodies and other governmental authorities; product quality, manufacturing or supply, or patient safety issues; changes in law and regulations; and other risks identified in Baxter’s most recent filing on Form 10-K and Form 10-Q and other SEC filings, all of which are available on Baxter’s website. Baxter does not undertake to update its forward-looking statements.

Hemopatch Sealing Hemostatand Baxter are registered trademarks of Baxter International Inc.

1 Lombardo C, Lopez-Ben S, Boggi U, Gutowski P, Hrbac T, Krska L, Marquez-Rivas J, Russello D, York E, Zacharias M. Hemopatch® is effective and safe to use: real-world data from a prospective European registry study. Updates Surg. 2022 Oct;74(5):1521-1531. doi: 10.1007/s13304-022-01353-y. Epub 2022 Aug 20. PMID: 35986865; PMCID: PMC9481486.

2 Prof. Dr. med. Selman Uranüs, is one of the speakers at the symposium and has signed a speaker agreement

3 IFU Hemopatch Sealing Hemostat 09/2024

Media Contact

Peggy Dekker-Kühnen, (224) 948-5353

[email protected]

Investor Contact

Clare Trachtman, (224) 948-3020

KEYWORDS: Austria Europe United States North America Illinois

INDUSTRY KEYWORDS: Surgery Medical Devices Hospitals Health Health Technology

MEDIA:

Posted on

CELEBRITY CRUISES’ MUCH-LOVED SHIP CELEBRITY APEX® RETURNS TO SOUTHAMPTON FOR 2025 SUMMER SEASON FROM THE UK

PR Newswire

Travelers can experience a variety of exciting four-to-14-night vacations on the state-of-the-art ship, which will cruise from Southampton from April through October. 


MIAMI
, April 10, 2025 /PRNewswire/ — Back by popular demand for her second summer season from Southampton, Celebrity Cruises®’ award-winning ship, Celebrity Apex® is offering itineraries to stunning destinations in 2025, from Northern Europe to Ibiza and the Canary Islands, including the premium cruise line’s first ever Presidents’ Cruise sailing in the Norwegian Fjords.

“Guests told us how much they loved the amazing itineraries we offered with our Celebrity Apex sailings last year, so we’re excited to homeport this revolutionary ship in Southampton again this summer,” said Laura Hodges Bethge, President of Celebrity Cruises. “I am excited to join Apex this May for the 2025 President’s Cruise and spend time enjoying the incredible Norwegian Fjords itinerary alongside our guests.” 

Sailing out of Southampton from Sunday, April 13, guests can experience Celebrity Apex’s elevated vacation experience direct from a UK port as the ship kicks off her European season with an 11-night sailing to the Canary Islands and Portugal. A serene and beautiful journey awaits through idyllic locations and much-loved destinations, including calls to Lisbon, Portugal where guests can steep themselves in the city’s history and walk along elaborate, mosaic-tiled sidewalks and Gran Canaria in the Canary Islands, famed for its rugged coastline, sandy beaches and variety of natural wonders that have earned it the nickname “The Small Continent.”

Celebrity Apex, the second ship in the game-changing Edge® Series, modernizes the way guests see the world, featuring an innovative outward-facing design and visionary spaces that stand apart from anything else at sea. Onboard, Celebrity Apex takes elevated cruising to a whole new level, with enhanced food and drink offerings, sought-after spa and wellness amenities, and high-energy entertainment that rival performances on land.

Departing on May 17, 2025, Celebrity’s much anticipated annual President’s Cruise offers an elevated vacation with a breathtaking week of extraordinary experiences, exciting surprises, and a chance for Captain’s Club℠ members to get to know Celebrity Cruises’ executive team. Among the activities guests will enjoy on the one-of-a-kind sailing are culinary events, hosted by Celebrity Cruises’ chefs, including Celebrity’s global culinary ambassador – renowned chef Daniel Boulud, exclusive entertainment performances and specially curated shore excursions hosted by Celebrity Cruises President, Laura Hodges Bethge.

Distinctive features set Celebrity Apex apart, showcasing contemporary design elements that are a favorite of Celebrity’s Edge Series ships. Celebrated experiences include the cantilevered multi-purpose venue, the Magic Carpet®, which invites guests to eat, drink and soar over the sea while discovering the greatest views that Europe has to offer; The Retreat®, complete with a private restaurant, Luminae, lounge area and sundeck exclusive to its guests; dramatically expanded Infinite Veranda® staterooms; soothing escapes at the Rooftop Garden; and, magnificent two-story Edge Villas, each with their own private terrace and plunge pool.

With 29 restaurants, bars, and lounges to explore onboard, Celebrity Apex boasts unforgettable culinary experiences, where guests can try delicious, globally inspired menus. From Fine Cut Steakhouse to Raw on 5 and Eden, guests can discover a range of worldly culinary delights offering mouth-watering flavors in a truly elevated specialty dining experience.

Endless vibrant entertainment offerings can also be found onboard, including three exclusive stage shows in The Theatre. Relive the dramatic performances that have defined entertainment decade after decade with Rockumentary, experience an uplifting journey through the seasons of life and the moments that bring us all together with Tree of Life, and enjoy electrifying pop violin music, mesmerizing choreography and aerial acrobatics with Crystallize. The entertainment doesn’t stop there as guests are drawn into an intimate cabaret show in The Club, along with a variety of themed experiences and activities throughout the ship.

For more information on Celebrity Apex offerings and destinations, and to book a vacation with Celebrity Cruises, please visit www.celebritycruises.com, contact a trusted travel advisor, or call Celebrity Cruises at 1-888-751-7804.

Editor’s Note:

Media can stay current on all Celebrity Cruises news at www.celebritycruisespresscenter.com 

About Celebrity Cruises 
Celebrity Cruises delivers an elevated premium vacation experience across their fleet of ships traveling to nearly 300 destinations across more than 70 countries spanning all seven continents. Uniquely offering the intimate feel and thoughtful service of small ships, with the variety and excitement of bigger ones – guests can explore the world or get away from it for a little while. With every detail elevated beyond expectations, guests will never want to vacation any other way. An industry pioneer for more than 35 years, each Celebrity vacation offers experiences you won’t find anywhere else aboard ships which continue to shatter industry expectations with the highly anticipated Celebrity Xcel® arriving Fall 2025.

Celebrity Cruises is headquartered in Miami and is one of five cruise brands owned by Royal Caribbean Group (NYSE: RCL). Visit www.celebritycruises.com for more information, and connect with us on Instagram, Facebook or LinkedIn.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/celebrity-cruises-much-loved-ship-celebrity-apex-returns-to-southampton-for-2025-summer-season-from-the-uk-302425664.html

SOURCE Celebrity Cruises

Posted on

U.S. FDA clears first stapler designed for single-port robotic surgery

Intuitive’s SureForm 45 stapler available for thoracic, colorectal, and urology procedures

SUNNYVALE, Calif., April 10, 2025 (GLOBE NEWSWIRE) — Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced that the U.S. Food & Drug Administration (FDA) cleared the company’s fully wristed SP SureForm 45 stapler for use with its da Vinci SP surgical system in thoracic, colorectal, and urologic procedures.

Like its multiport counterparts, the SP SureForm 45 features SmartFire technology, which continuously monitors tissue compression before and during firing. This real-time optimization helps surgeons enhance staple line integrity and reduce the risk of tissue damage across varying thicknesses.

“Being able to use a SureForm 45 stapler in single-port robotic surgery helps provide surgeons with more control of their procedures from the da Vinci surgeon console, without the need to rely on an assistant to fire a stapler. This kind of control can help save valuable operating time,” said Intuitive Chief Medical Officer Myriam Curet, M.D.

The da Vinci SP system provides surgeons with robotic-assisted technology, enabling them to perform procedures with innovative approaches that help promote faster patient recovery and reduce postoperative pain.

These innovative surgical approaches are made possible by surgeon control of up to three wristed instruments and a high definition (HD), three-dimensional (3D) camera. The instruments—including the SureForm 45 stapler—–and camera enter through a single access point and triangulate inside the body, helping eliminate external instrument collisions that can occur in small surgical workspaces.

The da Vinci SP surgical system is approved for use across a variety of surgical procedures in Europe, Japan, Korea, and Taiwan. In the U.S., the FDA has cleared the da Vinci SP surgical system for urology, transoral otolaryngology, colorectal, and thoracic procedures. The SP SureForm 45 stapler has received FDA clearance for thoracic, colorectal, and urology procedures, though it is not cleared for transoral otolaryngology procedures.

Da Vinci SP is part of Intuitive’s portfolio of surgical systems. The da Vinci 5, Xi, and X are Intuitive’s multi-port surgical systems, now in its fifth generation of innovative technology.

Contact Information: Peper Long, Intuitive
+1 202-997-7373
[email protected]

About Intuitive

Intuitive (NASDAQ:ISRG), headquartered in Sunnyvale, California, is a global leader in minimally invasive care and the pioneer of robotic surgery. Our technologies include the da Vinci surgical system and the Ion endoluminal system. By uniting advanced systems, progressive learning, and value-enhancing services, we help physicians and their teams optimize care delivery to support the best outcomes possible. At Intuitive, we envision a future of care that is less invasive and profoundly better, where disease is identified early and treated quickly, so that patients can get back to what matters most.

About da Vinci Surgical Systems

There are several models of the da Vinci surgical system. The da Vinci surgical systems are designed to help surgeons perform minimally invasive surgery and offer surgeons high-definition 3D vision, a magnified view, and robotic and computer assistance. They use specialized instrumentation, including a miniaturized surgical camera and wristed instruments (i.e., scissors, scalpels, and forceps) that are designed to help with precise dissection and reconstruction deep inside the body.

For more information, please visit the company’s website at www.intuitive.com.

Important Safety Information

For product intended use and/or indications for use, risks, cautions, and warnings and full prescribing information, visit https://manuals.intuitivesurgical.com/market. For summary of the risks associated with surgery refer to www.intuitive.com/safety.

Forward-Looking Statements

This press release contains forward-looking statements which relate to expectations concerning matters that are not historical facts. Statements using words such as “estimates,” “projects,” “believes,” “anticipates,” “plans,” “expects,” “intends,” “may,” “will,” “can,” “could,” “should,” “would,” “targeted,” “potential,” and similar words and expressions are intended to identify forward-looking statements. These forward-looking statements are necessarily estimates reflecting the judgment of Intuitive’s management and involve a number of risks and uncertainties that could cause actual results or impacts on its operations, financial performance, and business position to differ materially from those suggested by the forward-looking statements. These forward-looking statements include, but are not limited to, statements related to research and development of products and services, manufacturing of products, obtaining of regulatory approvals, technical and other performance of products and services, and making products and services available to more patients and health care professionals. These forward-looking statements should be considered in light of various important factors and involve known and unknown risks, uncertainties, and other factors, which may cause the actual results, performance, or achievements of Intuitive, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements include, among others, economic conditions in the geographic markets in which we operate, changes in governmental regulations, regulatory approval priorities, resources, and timelines, regulatory enforcement priorities, governmental investigations and civil litigation, and other factors discussed in Intuitive’s Annual Reports and other filings with relevant securities regulators.

Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release and which are based on current expectations and are subject to risks, uncertainties, and assumptions that are difficult to predict, including those risk factors identified under the heading “Risk Factors” in Intuitive’s Annual Report on Form 10-K for the year ended December 31, 2024, as updated by its other filings with the U.S. Securities and Exchange Commission. Intuitive’s actual results may differ materially and adversely from those expressed in any forward-looking statements, and it undertakes no obligation to publicly update or release any revisions to these forward-looking statements, except as required by law.